FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis

As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news